Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Current Deferred Tax Assets: 2010-2015

Historic Current Deferred Tax Assets for BIO-TECHNE (TECH) over the last 4 years, with Jun 2015 value amounting to $11.5 million.

  • BIO-TECHNE's Current Deferred Tax Assets fell 12.05% to $11.5 million in Q4 2015 from the same period last year, while for Dec 2015 it was $11.5 million, marking a year-over-year decrease of 12.05%. This contributed to the annual value of $11.5 million for FY2015, which is 19.62% up from last year.
  • As of FY2015, BIO-TECHNE's Current Deferred Tax Assets stood at $11.5 million, which was up 19.62% from $9.6 million recorded in FY2014.
  • Over the past 5 years, BIO-TECHNE's Current Deferred Tax Assets peaked at $11.5 million during FY2015, and registered a low of $5.8 million during FY2011.
  • In the last 2 years, BIO-TECHNE's Current Deferred Tax Assets had a median value of $10.6 million in 2014 and averaged $10.6 million.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first plummeted by 56.67% in 2011, then climbed by 19.62% in 2015.
  • Over the past 3 years, BIO-TECHNE's Current Deferred Tax Assets (Yearly) stood at $5.8 million in 2011, then reached $9.6 million in 2014, then rose by 19.62% to $11.5 million in 2015.